Clinical Trial Update: An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens [Phase 3]

View source ↗

Summary

This Phase 3 trial completed evaluating whether intravenous gamma globulin improves kidney transplant survival in highly sensitized patients with end-stage rena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplantation

Drugs mentioned

• Intravenous gamma globulin (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: End-Stage Renal Disease, Kidney Transplantation | Phase 3 | Status: COMPLETED